AAAAAA

   
Results: 1-12 |
Results: 12
FAMILIAR HISTORY IN BREAST CONSERVATIVE TREATMENT OF BREAST-CANCER A GOOD PROGNOSTIC FACTOR
Authors: JOBSEN JJ MEERWALDT JH HELLE PA MULDER HJ NOACH P
Citation: Jj. Jobsen et al., FAMILIAR HISTORY IN BREAST CONSERVATIVE TREATMENT OF BREAST-CANCER A GOOD PROGNOSTIC FACTOR, European journal of cancer, 34, 1998, pp. 446-446
AGE THE LIMITING FACTOR FOR BREAST CONSERVATIVE TREATMENT IN T1 BREAST-CANCER
Authors: JOBSEN JJ MEERWALDT JH MULDER HJ VONREIJN M
Citation: Jj. Jobsen et al., AGE THE LIMITING FACTOR FOR BREAST CONSERVATIVE TREATMENT IN T1 BREAST-CANCER, European journal of cancer, 34, 1998, pp. 462-462
MAINTENANCE OF REMISSION WITH HUMAN RECOMBINANT INTERFERON ALFA-2A INPATIENTS WITH STAGE-III AND STAGE-IV LOW-GRADE MALIGNANT NON-HODGKINS-LYMPHOMA
Authors: HAGENBEEK A CARDE P MEERWALDT JH SOMERS R THOMAS J DEBOCK R RAEMAEKERS JMM VANHOOF A DEWOLFPEETERS C VANGLABBEKE M
Citation: A. Hagenbeek et al., MAINTENANCE OF REMISSION WITH HUMAN RECOMBINANT INTERFERON ALFA-2A INPATIENTS WITH STAGE-III AND STAGE-IV LOW-GRADE MALIGNANT NON-HODGKINS-LYMPHOMA, Journal of clinical oncology, 16(1), 1998, pp. 41-47
COMBINED-MODALITY TREATMENT IS THE TREATMENT OF CHOICE FOR STAGE I IEINTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMAS/
Authors: VANDERMAAZEN RWM NOORDIJK EM THOMAS J RAEMAEKERS JMM MEERWALDT JH
Citation: Rwm. Vandermaazen et al., COMBINED-MODALITY TREATMENT IS THE TREATMENT OF CHOICE FOR STAGE I IEINTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMAS/, British Journal of Haematology, 102(1), 1998, pp. 149-149
RADIATION-INDUCED XEROSTOMIA - PATHOPHYSIOLOGY, CLINICAL COURSE AND SUPPORTIVE TREATMENT
Authors: GUCHELAAR HJ VERMES A MEERWALDT JH
Citation: Hj. Guchelaar et al., RADIATION-INDUCED XEROSTOMIA - PATHOPHYSIOLOGY, CLINICAL COURSE AND SUPPORTIVE TREATMENT, Supportive care in cancer, 5(4), 1997, pp. 281-288
PERSISTENT IMPROVED RESULTS AFTER ADDING VINCRISTINE AND BLEOMYCIN TOA CYCLOPHOSPHAMIDE HYDROXORUBICIN/VM-26/PREDNISONE COMBINATION (CHVMP) IN STAGE III-IV INTERMEDIATE-GRADE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA/
Authors: MEERWALDT JH CARDE P SOMERS R THOMAS J KLUINNELEMANS JC BRON D NOORDIJK EM COSSET JM BIJNENS L TEODOROVIC I HAGENBEEK A
Citation: Jh. Meerwaldt et al., PERSISTENT IMPROVED RESULTS AFTER ADDING VINCRISTINE AND BLEOMYCIN TOA CYCLOPHOSPHAMIDE HYDROXORUBICIN/VM-26/PREDNISONE COMBINATION (CHVMP) IN STAGE III-IV INTERMEDIATE-GRADE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA/, Annals of oncology, 8, 1997, pp. 67-70
CLINICAL ANALYSIS OF 670 CASES IN 2 TRIALS OF THE EUROPEAN ORGANIZATION FOR THE RESEARCH AND TREATMENT OF CANCER LYMPHOMA COOPERATIVE GROUPSUBTYPED ACCORDING TO THE REVISED EUROPEAN-AMERICAN CLASSIFICATION OFLYMPHOID NEOPLASMS - A COMPARISON WITH THE WORKING FORMULATION
Authors: PITTALUGA S BIJNENS L TEODOROVIC I HAGENBEEK A MEERWALDT JH SOMERS R THOMAS J NOORDIJK EM DEWOLFPEETERS C
Citation: S. Pittaluga et al., CLINICAL ANALYSIS OF 670 CASES IN 2 TRIALS OF THE EUROPEAN ORGANIZATION FOR THE RESEARCH AND TREATMENT OF CANCER LYMPHOMA COOPERATIVE GROUPSUBTYPED ACCORDING TO THE REVISED EUROPEAN-AMERICAN CLASSIFICATION OFLYMPHOID NEOPLASMS - A COMPARISON WITH THE WORKING FORMULATION, Blood, 87(10), 1996, pp. 4358-4367
EFFICACY OF 4 DIFFERENT REGIMENS IN 64 MANTLE-CELL LYMPHOMA CASES - CLINICOPATHOLOGICAL COMPARISON WITH 498 OTHER NON-HODGKINS-LYMPHOMA SUBTYPES
Authors: TEODOROVIC I PITTALUGA S KLUINNELEMANS JC MEERWALDT JH HAGENBEEK A VANGLABBEKE M SOMERS R BIJNENS L NOORDIJK EM PEETERS CD
Citation: I. Teodorovic et al., EFFICACY OF 4 DIFFERENT REGIMENS IN 64 MANTLE-CELL LYMPHOMA CASES - CLINICOPATHOLOGICAL COMPARISON WITH 498 OTHER NON-HODGKINS-LYMPHOMA SUBTYPES, Journal of clinical oncology, 13(11), 1995, pp. 2819-2826
PEROPERATIVE BRACHYTHERAPY WITH THE USE OF A VICRYL(R) MAT IN ADVANCED OR RECURRENT PELVIC TUMORS
Authors: MEERWALDT JH WIGGERS T VISSER AG SLOT A
Citation: Jh. Meerwaldt et al., PEROPERATIVE BRACHYTHERAPY WITH THE USE OF A VICRYL(R) MAT IN ADVANCED OR RECURRENT PELVIC TUMORS, Radiotherapy and oncology, 37(2), 1995, pp. 167-169
RADIATION-INDUCED LUNG DAMAGE AFTER THORACIC IRRADIATION FOR HODGKINS-DISEASE - THE ROLE OF FRACTIONATION
Authors: DUBRAY B HENRYAMAR M MEERWALDT JH NOORDIJK EM DIXON DO COSSET JM THAMES HD
Citation: B. Dubray et al., RADIATION-INDUCED LUNG DAMAGE AFTER THORACIC IRRADIATION FOR HODGKINS-DISEASE - THE ROLE OF FRACTIONATION, Radiotherapy and oncology, 36(3), 1995, pp. 211-217
CLINICAL STAGING VERSUS LAPAROTOMY AND COMBINED-MODALITY WITH MOPP VERSUS ABVD IN EARLY-STAGE HODGKINS-DISEASE - THE H6 TWIN RANDOMIZED TRIALS FROM THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER LYMPHOMA COOPERATIVE GROUP
Authors: CARDE P HAGENBEEK A HAYAT M MONCONDUIT M THOMAS J BURGERS MJV NOORDIJK EM TANGUY A MEERWALDT JH LEFUR R SOMERS R KLUINNELEMANS HC BUSSON A BREED WP BRON D HOLDRINET A RUTTEN EHJM MICHIELS JJ REGNIER R DEBUSSCHER L MUSELLA R FARGEOT P THYSS A CATTAN A RIGALHUGUET F ROTH S CAILLOU B DUPOUY N HENRYAMAR M
Citation: P. Carde et al., CLINICAL STAGING VERSUS LAPAROTOMY AND COMBINED-MODALITY WITH MOPP VERSUS ABVD IN EARLY-STAGE HODGKINS-DISEASE - THE H6 TWIN RANDOMIZED TRIALS FROM THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER LYMPHOMA COOPERATIVE GROUP, Journal of clinical oncology, 11(11), 1993, pp. 2258-2272
A PREDICTIVE MODEL FOR AGGRESSIVE NON-HODGKINS-LYMPHOMA
Authors: SHIPP MA HARRINGTON DP ANDERSON JR ARMITAGE JO BONADONNA G BRITTINGER G CABANILLAS F CANELLOS GP COIFFIER B CONNORS JM COWAN RA CROWTHER D DAHLBERG S ENGELHARD M FISHER RI GISSELBRECHT C HORNING SJ LEPAGE E LISTER TA MEERWALDT JH MONTSERRAT E NISSEN NI OKEN MM PETERSON BA TONDINI C VELASQUEZ WA YEAP BY
Citation: Ma. Shipp et al., A PREDICTIVE MODEL FOR AGGRESSIVE NON-HODGKINS-LYMPHOMA, The New England journal of medicine, 329(14), 1993, pp. 987-994
Risultati: 1-12 |